We are live on
!
Find out more
Vertex Pharmaceuticals
VRTX
VRTX
489 hedge funds and large institutions have $20.9B invested in Vertex Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 45 funds opening new positions, 188 increasing their positions, 178 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
29% more first-time investments, than exits
New positions opened: 45 | Existing positions closed: 35
1% more funds holding
Funds holding: 482 → 489 (+7)
9% more call options, than puts
Call options by funds: $95.6M | Put options by funds: $87.9M
6% more repeat investments, than reductions
Existing positions increased: 188 | Existing positions reduced: 178
1% more capital invested
Capital invested by funds: $20.7B → $20.9B (+$225M)
33% less funds holding in top 10
Funds holding in top 10: 6 → 4 (-2)
Holders
489
Holders Change
+7
Holders Change %
+1.45%
% of All Funds
13.05%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.11%
New
45
Increased
188
Reduced
178
Closed
35
Calls
$95.6M
Puts
$87.9M
Net Calls
+$7.73M
Net Calls Change
+$7.24M
Top Buyers
| 1 |
Jennison Associates
New York
|
+$208M |
| 2 |
State Street
Boston,
Massachusetts
|
+$155M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$67.2M |
| 4 |
Capital World Investors
Los Angeles,
California
|
+$56.7M |
| 5 |
Morgan Stanley
New York
|
+$50M |
Top Sellers
| 1 |
GE
General Electric
Evendale,
Ohio
|
-$111M |
| 2 |
JP Morgan Chase
New York
|
-$108M |
| 3 |
American Century Companies
Kansas City,
Missouri
|
-$55.3M |
| 4 |
O
OrbiMed
New York
|
-$54.6M |
| 5 |
D.E. Shaw & Co
New York
|
-$49.9M |
